MedTrace Logo

Apnea Positive Pressure Long-Term Efficacy Study

NCT00051363 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 1105

Last updated 2018-11-28

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine the effectiveness of nasal continuous positive airway pressure (CPAP) therapy for the treatment of obstructive sleep apnea syndrome (OSAS).

Conditions

  • Lung Diseases
  • Sleep Apnea Syndromes
  • Sleep

Interventions

DEVICE

Active CPAP

Nightly nasal continuous positive airway pressure (CPAP)

DEVICE

Sham CPAP

Sham CPAP machine will be used for participants in the placebo group.

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH

  • Stanford University

    lead OTHER

Principal Investigators

  • William C. Dement, MD, PhD · Stanford University

  • Clete A. Kushida, MD, PhD · Stanford University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-09-30
Primary Completion
2008-08-31
Completion
2008-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00051363 on ClinicalTrials.gov